By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cipla Ltd. 

Mumbai Central

Mumbai    400 008  India
Phone: 91-22-308-2891-or-91-22-309-5521 Fax: 91-22-307-0013



Company News
American Cancer Society And Clinton Health Access Initiative Announce Collaborations With Pfizer (PFE) And Cipla (CIPLA) To Increase Access To Lifesaving Cancer Treatment In Africa 6/20/2017 9:27:43 AM
India's Third Largest Drugmaker Cipla (CIPLA) Freezes Pay for 300 to 400 Top Managers 9/29/2016 7:31:23 AM
Cipla (CIPLA) Announces Q1 FY17 Results Performance Reflects Continued Momentum In Key Markets And Improvement In Base EBITDA Margins 8/15/2016 3:44:53 PM
Cipla (CIPLA) Release: Declaration By The Pharmaceutical, Biotechnology And Diagnostics Industries On Combating Antimicrobial Resistance 8/15/2016 3:39:40 PM
BioQ And Cipla (CIPLA) Enter Into An Agreement To Commercialize BioQ’s Ropivacaine Infusion System In India 8/15/2016 3:26:07 PM
Cipla (CIPLA) Announces its Management Council 8/15/2016 3:21:19 PM
Cipla (CIPLA) Release: The Medicines Patent Pool Signs First Sub-Licences For Hepatitis C Medicine Daclatasvir 8/15/2016 3:19:30 PM
Cipla (CIPLA) Release: CARE Reaffirms ‘CARE AAA / A1+’ Rating 8/15/2016 3:15:00 PM
Cipla (CIPLA) Announces Q3 FY1516 Unaudited Consolidated Financial Results 8/15/2016 3:13:10 PM
Cipla (CIPLA) Completes Acquisition Of Generic Businesses In US 8/15/2016 3:10:38 PM